<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>25(1)</volume><submitter>Fu C</submitter><journal>BMC gastroenterology</journal><pagination>650</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12465505</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Association between the ApoB/ApoA1 ratio and both the severity and mortality of metabolic dysfunction-associated fatty liver disease.</pubmed_title><pmcid>PMC12465505</pmcid><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Fu C</pubmed_authors><pubmed_authors>Han B</pubmed_authors><pubmed_authors>He D</pubmed_authors><pubmed_authors>Zeng Q</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Wang F</pubmed_authors><pubmed_authors>Wang G</pubmed_authors><pubmed_authors>Gao X</pubmed_authors><pubmed_authors>Liu S</pubmed_authors><pubmed_authors>Gong Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association between the ApoB/ApoA1 ratio and both the severity and mortality of metabolic dysfunction-associated fatty liver disease.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-03T21:43:18.511Z</modification><creation>2026-05-02T03:07:54.714Z</creation></dates><accession>S-EPMC12465505</accession><cross_references><pubmed>41013261</pubmed><doi>10.1186/s12876-025-04130-4</doi></cross_references></HashMap>